Biomaterials for Immuno-Engineering Lab develops biomaterials to tackle problems in immunology and immunotherapy. Balanced immunity is essential for our health, as weak immunity is susceptible for infection and tumorigenesis whereas over-activation of immunity can cause autoimmune diseases and hyper-inflammation (e.g. severe COVID-19). We develop biomaterial-based approaches to monitor and control immune system to deepen our understanding and to treat immune-related diseases. In particular, we are interested in cancer immunotherapy, a therapy to treat cancer by harnessing the power of immunity. Biomaterial-based ex vivo models recapitulating tumor-immune microenvironment (TIME) can be useful in understanding fundamental mechanisms underlying cancer immunotherapy. Biomaterial-based delivery system will allow us to deliver various therapeutics to TIME in a spatio-temporally controlled manner to maximize efficacy and minimize toxicity.

